Treg-enriched CD4+T cells attenuate collagen synthesis in keloid fibroblasts

被引:44
|
作者
Murao, Naoki [1 ]
Seino, Ken-ichiro [2 ]
Hayashi, Toshihiko [1 ,3 ]
Ikeda, Masaki [1 ]
Funayama, Emi [1 ]
Furukawa, Hiroshi [1 ]
Yamamoto, Yuhei [1 ]
Oyama, Akihiko [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Inst Med Genet, Div Immunobiol, Sapporo, Hokkaido 0608638, Japan
[3] Hokkaido Univ, Grad Sch Dent Med, Dept Oral & Maxillofacial Surg, Sapporo, Hokkaido 0608638, Japan
关键词
coculture; fibroblast; keloid; regulatory T cell; REGULATORY T-CELLS; GENE-EXPRESSION; HYPERTROPHIC SCARS; SYSTEMIC-SCLEROSIS; I COLLAGEN; TGF-BETA; EXPANSION; PATHOPHYSIOLOGY; INTERLEUKIN-10; PATHOGENESIS;
D O I
10.1111/exd.12368
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keloid is an inflammatory and fibrotic disease with an unknown pathogenesis. Regulatory T cells (Tregs) of CD4+ lineage can suppress other effector CD4+ T cells and modulate the immune response. A relative decrease in the number of Tregs may be involved in the pathogenesis of inflammatory and fibrotic diseases. We therefore investigated the number of Tregs in keloids using immunohistochemistry and examined the interaction between Tregs and keloid fibroblasts (KFs) using a coculture system. It was found that the ratio of Tregs/CD4+ T cells was lower compared with that in other common inflammatory skin conditions. In addition, Treg-enriched CD4+ T cells reduced collagen synthesis by KFs. Our findings suggest that a local imbalance of Tregs contributes to the development of keloids and that correction of this imbalance might represent a novel therapeutic approach to keloid fibrosis.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 50 条
  • [31] SYSTEMIC IMMUNOSUPPRESSION OF CD4+T HELPER CELLS IN GLIOMA
    Mohme, Malte
    Maire, Cecile
    Runger, Alessandra
    Glau, Laura
    Tolosa, Eva
    Westphal, Manfred
    Lamszus, Katrin
    NEURO-ONCOLOGY, 2021, 23 : 95 - 95
  • [32] CD4+T CELLS RESTRICT MEDULLOBLASTOMA GROWTH AND DISSEMINATION
    Eisemann, Tanja
    Wechsler-Reya, Robert
    NEURO-ONCOLOGY, 2020, 22 : 115 - 115
  • [33] Role of CD4+T Cells in Parkinson?s Disease
    Ghanta, Mohan Krishna
    Nuthalapati, Poojith
    Merchant, Neha
    Chenchula, Santenna
    Hussain, Faiz
    Khan, A. K. Afzal
    Bhaskar, L. V. K. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (06) : 17 - 26
  • [34] Platelets induce a regulatory phenotype in CD4+T cells
    Zimmer, N.
    Hahn, S. A.
    Tuettenberg, A.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E53 - E53
  • [35] Roles of CD4+T cells as mediators of antitumor immunity
    Kravtsov, Dmitriy S. S.
    Erbe, Amy K. K.
    Sondel, Paul M. M.
    Rakhmilevich, Alexander L. L.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] CD4+T cells promoting humoral responses in mice
    Eddahri, Fouad
    Denanglaire, Sebastien
    Leol, Oberdan
    Andris, Fabienne
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [37] CD4+T cells aggravate hemorrhagic brain injury
    Shi, Samuel X.
    Xiu, Yuwen
    Li, Yan
    Yuan, Meng
    Shi, Kaibin
    Liu, Qiang
    Wang, Xiaoying
    Jin, Wei-Na
    SCIENCE ADVANCES, 2023, 9 (23)
  • [38] Induction and functionality of hepatic regulatory CD4+T cells
    Rudolph, C.
    Kruse, N.
    Neumann, K.
    Erben, U.
    Kuehl, A.
    Derkow, A.
    Schott, E.
    Zeitz, M.
    Hamann, A.
    Klugewitz, K.
    IMMUNOLOGY, 2012, 137 : 503 - 503
  • [39] Expression of retention integrins by human CD4+T cells
    Lynch, Kevin
    Melssen, Marit
    Olson, Walter
    Slingluff, Craig
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [40] Circadian Clocks in Mouse and Human CD4+T Cells
    Bollinger, Thomas
    Leutz, Anton
    Leliavski, Alexei
    Skrum, Ludmila
    Kovac, Judit
    Bonacina, Luigi
    Benedict, Christian
    Lange, Tanja
    Westermann, Juergen
    Oster, Henrik
    Solbach, Werner
    PLOS ONE, 2011, 6 (12):